GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » EV-to-FCF

Orion Infusions (DHA:ORIONINFU) EV-to-FCF : 3,905.37 (As of Jul. 03, 2025)


View and export this data going back to . Start your Free Trial

What is Orion Infusions EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Orion Infusions's Enterprise Value is BDT6,674.3 Mil. Orion Infusions's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was BDT1.7 Mil. Therefore, Orion Infusions's EV-to-FCF for today is 3,905.37.

The historical rank and industry rank for Orion Infusions's EV-to-FCF or its related term are showing as below:

DHA:ORIONINFU' s EV-to-FCF Range Over the Past 10 Years
Min: -2288.43   Med: 39.98   Max: 4860.96
Current: 3908.94

During the past 13 years, the highest EV-to-FCF of Orion Infusions was 4860.96. The lowest was -2288.43. And the median was 39.98.

DHA:ORIONINFU's EV-to-FCF is ranked worse than
99.63% of 537 companies
in the Drug Manufacturers industry
Industry Median: 24.99 vs DHA:ORIONINFU: 3908.94

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-07-03), Orion Infusions's stock price is BDT313.40. Orion Infusions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was BDT2.027. Therefore, Orion Infusions's PE Ratio (TTM) for today is 154.61.


Orion Infusions EV-to-FCF Historical Data

The historical data trend for Orion Infusions's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions EV-to-FCF Chart

Orion Infusions Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.34 261.40 79.74 -989.38 218.93

Orion Infusions Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 276.92 218.93 161.12 236.10 4,838.23

Competitive Comparison of Orion Infusions's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Orion Infusions's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Infusions's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Infusions's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Orion Infusions's EV-to-FCF falls into.


;
;

Orion Infusions EV-to-FCF Calculation

Orion Infusions's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=6674.270/1.709
=3,905.37

Orion Infusions's current Enterprise Value is BDT6,674.3 Mil.
Orion Infusions's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT1.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orion Infusions  (DHA:ORIONINFU) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Orion Infusions's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=313.40/2.027
=154.61

Orion Infusions's share price for today is BDT313.40.
Orion Infusions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT2.027.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Orion Infusions EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Orion Infusions's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Infusions Business Description

Traded in Other Exchanges
N/A
Address
153-154 Tejgaon I/A, Orion House, Dhaka, BGD, 1208
Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions Headlines

No Headlines